The Centers for Disease Control and Prevention has released an initial document intended to assist jurisdictions across the country in planning for the distribution and administration of COVID-19 vaccines to the pediatric population. The document provides information pertaining to pediatric COVID-19 vaccines and several assumptions that can be made about the pediatric COVID-19 vaccination program. The document also highlights packaging changes and storage requirements for the Pfizer pediatric COVID-19 vaccine for children ages 5-11. AHA anticipates the availability of more detailed information in the coming days and weeks and will share those updates as new information is released.